Euro-Diagnostica
Provider of cell-based reporter-gene functional bioassays, complement system activity and biomarker assays, bioanalytical CRO services and diagnostic laboratory testing. Offers assay-ready cryopreserved cell lines, custom cell-line development and master cell banking, ELISA and functional complement assays, AAV immunogenicity and transduction inhibition testing, and biomarker discovery services supported by proteomics and LC-MS/MS capabilities. Services support discovery, preclinical and clinical phases for pharma, biotech, CROs and clinical laboratories.
Industries
Nr. of Employees
medium (51-250)
Euro-Diagnostica
Malmö, Skane Lan, Sweden, Europe
Products
Assay-ready reporter-gene cell lines
Cryopreserved reporter and target cell lines provided in assay-ready format for ADCC, ADCP, T-cell activation, cytokine and complement functional testing.
Complement functional and biomarker assay kits
ELISA-based kits and functional assays to measure activity of classical, lectin and alternative complement pathways and specific activation products for research and safety testing.
AAV immunogenicity assay suite
Serotype-specific ELISA for AAV-triggered complement activation and cell-based transduction inhibition assays for neutralizing antibody detection, with options for serotype customization.
Assay-ready reporter-gene cell lines
Cryopreserved reporter and target cell lines provided in assay-ready format for ADCC, ADCP, T-cell activation, cytokine and complement functional testing.
Complement functional and biomarker assay kits
ELISA-based kits and functional assays to measure activity of classical, lectin and alternative complement pathways and specific activation products for research and safety testing.
AAV immunogenicity assay suite
Serotype-specific ELISA for AAV-triggered complement activation and cell-based transduction inhibition assays for neutralizing antibody detection, with options for serotype customization.
Services
Preclinical and clinical bioanalytical services including immunogenicity testing, PK/PD, TK, biomarker testing, potency testing, assay development and sample analysis in a GxP/GMP environment.
Bioassay qualification and validation, lot-release potency testing, stability and in-process testing to support biologics and biosimilars quality control.
Assay design, assay optimization, sample analysis and data processing for biomarker discovery, integrating targeted proteomics platforms.
Clinical diagnostic testing and therapeutic drug monitoring for autoimmune, neurology and other specialized diagnostic panels, with urgent testing and electronic reporting options.
Custom reporter and target cell-line creation, conversion of sponsor material into assay-ready cells, and master cell bank development for tailored assay and production needs.
Preclinical and clinical bioanalytical services including immunogenicity testing, PK/PD, TK, biomarker testing, potency testing, assay development and sample analysis in a GxP/GMP environment.
Bioassay qualification and validation, lot-release potency testing, stability and in-process testing to support biologics and biosimilars quality control.
Assay design, assay optimization, sample analysis and data processing for biomarker discovery, integrating targeted proteomics platforms.
Clinical diagnostic testing and therapeutic drug monitoring for autoimmune, neurology and other specialized diagnostic panels, with urgent testing and electronic reporting options.
Custom reporter and target cell-line creation, conversion of sponsor material into assay-ready cells, and master cell bank development for tailored assay and production needs.
Expertise Areas
- Cell-based reporter-gene functional assays
- Complement system functional and biomarker testing
- Immunogenicity and neutralizing antibody assessment
- Bioanalytical CRO services (PK/PD, TK, immunogenicity)
Key Technologies
- Reporter-gene cell-based assays (luciferase readouts)
- Assay-ready cryopreserved cell formats
- Dual-reporter normalization
- ELISA and enzyme immunoassays
News & Updates
Participation at a conference focused on antibody engineering and therapeutics.
Participation at a summit focused on complement-based drug development.
Participation at a clinical conference on encephalitis and related neurological conditions.
Participation at a symposium on therapeutic drug monitoring of biologics.
Adoption of a targeted proteomics platform to enhance biomarker discovery services.
Anniversary and review of long-term use and impact of complement functional assays in research and diagnostics.
Participation at a conference focused on antibody engineering and therapeutics.
Participation at a summit focused on complement-based drug development.
Participation at a clinical conference on encephalitis and related neurological conditions.
Participation at a symposium on therapeutic drug monitoring of biologics.
Adoption of a targeted proteomics platform to enhance biomarker discovery services.
Anniversary and review of long-term use and impact of complement functional assays in research and diagnostics.